These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 639970)

  • 21. Comparison of WHO and US FDA biowaiver dissolution test conditions using bioequivalent doxycycline hyclate drug products.
    Strauch S; Jantratid E; Dressman JB
    J Pharm Pharmacol; 2009 Mar; 61(3):331-7. PubMed ID: 19222905
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pharmacokinetic models].
    Dahl S
    Tidsskr Nor Laegeforen; 1973 Jan; 93(3):157-62. PubMed ID: 4693373
    [No Abstract]   [Full Text] [Related]  

  • 23. [A pharmacokinetic function for galenics].
    Dost FH
    Arzneimittelforschung; 1971 May; 21(5):712-7. PubMed ID: 5109699
    [No Abstract]   [Full Text] [Related]  

  • 24. [Electrolytes of the blood and digestive gland juices in patients with chronic diseases of the digestive organs].
    Revutskiĭ BI
    Ter Arkh; 1970 Dec; 42(12):57-62. PubMed ID: 5511306
    [No Abstract]   [Full Text] [Related]  

  • 25. Biopharmaceutics classification systems for new molecular entities (BCS-NMEs) and marketed drugs (BCS-MD): theoretical basis and practical examples.
    Papadopoulou V; Valsami G; Dokoumetzidis A; Macheras P
    Int J Pharm; 2008 Sep; 361(1-2):70-7. PubMed ID: 18614303
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The influence of protonation ratio on properties of carboxymethyl starch excipient at various substitution degrees: Structural insights and drug release kinetics.
    Assaad E; Mateescu MA
    Int J Pharm; 2010 Jul; 394(1-2):75-84. PubMed ID: 20435114
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Simulation of fasting gastric conditions and its importance for the in vivo dissolution of lipophilic compounds.
    Vertzoni M; Dressman J; Butler J; Hempenstall J; Reppas C
    Eur J Pharm Biopharm; 2005 Aug; 60(3):413-7. PubMed ID: 15893920
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Influence of the starting materials on bioavailability of drugs].
    Bagnaresi P; Bulgarelli D; Calvi A; Ferrarini G
    Boll Chim Farm; 1973 Feb; 112(2):83-93. PubMed ID: 4719968
    [No Abstract]   [Full Text] [Related]  

  • 29. New compartment- and model-independent method for rapid calculation of drug absorption rates.
    Chiou WL
    J Pharm Sci; 1980 Jan; 69(1):57-62. PubMed ID: 7354444
    [No Abstract]   [Full Text] [Related]  

  • 30. Pharmacokinetics and their clinical significance.
    Garrett ER
    Int Z Klin Pharmakol Ther Toxikol; 1969 Jul; 2(3):193-6. PubMed ID: 5357862
    [No Abstract]   [Full Text] [Related]  

  • 31. Bioavailability and pharmacokinetic analysis of drug responding systems.
    Smolen VF
    Annu Rev Pharmacol Toxicol; 1978; 18():495-522. PubMed ID: 348066
    [No Abstract]   [Full Text] [Related]  

  • 32. Biopharmaceutical classification of drugs using intrinsic dissolution rate (IDR) and rat intestinal permeability.
    Zakeri-Milani P; Barzegar-Jalali M; Azimi M; Valizadeh H
    Eur J Pharm Biopharm; 2009 Sep; 73(1):102-6. PubMed ID: 19442726
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug permeation through membranes. II. Simultaneous dissolution and permeation of drug from solid dosage forms.
    Lovering EG; McRae KB
    J Pharm Sci; 1973 Jun; 62(6):971-4. PubMed ID: 4712634
    [No Abstract]   [Full Text] [Related]  

  • 34. Studies on the oral administration of saliva-parotin A. 3. The influences of the digestive juice and the liver upon the biological activities of saliva-parotin-A.
    Ito Y; Moriwaki C; Moriya H
    Endocrinol Jpn; 1966 Dec; 13(4):448-55. PubMed ID: 6013320
    [No Abstract]   [Full Text] [Related]  

  • 35. Development of sensor elements to control drug release from capsular drug delivery systems.
    Gröning R; Danco I; Müller RS
    Int J Pharm; 2007 Aug; 340(1-2):61-4. PubMed ID: 17462841
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of simulated intestinal fluid on drug permeability estimation across Caco-2 monolayers.
    Ingels F; Beck B; Oth M; Augustijns P
    Int J Pharm; 2004 Apr; 274(1-2):221-32. PubMed ID: 15072798
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The pharmacist's ability to use bioavailability data.
    Cronk JD; Williams RB; Moore WE
    Am J Hosp Pharm; 1975 Jan; 32(1):46-8. PubMed ID: 1124781
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pharmacokinetic aspects relevant to biopharmaceutics].
    Segre G
    Ann Ist Super Sanita; 1982; 18(3):533-40. PubMed ID: 7187841
    [No Abstract]   [Full Text] [Related]  

  • 39. 4-acetamidophenyl 2,2,2-trichlorethyl carbonate synthesis, physical properties, and in vitro hydrolysis.
    Swintosky JV; Caldwell HC; Chong CW; Irwin GM; Dittert LW
    J Pharm Sci; 1968 May; 57(5):752-6. PubMed ID: 5657530
    [No Abstract]   [Full Text] [Related]  

  • 40. Bioavailability of digoxin from tablets. I. In vitro characterization of digoxin tablets.
    Nyberg L; Bratt L; Forsgren A; Hugosson S
    Acta Pharm Suec; 1974 Nov; 11(5):447-58. PubMed ID: 4440503
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.